You are using an older browser version. Please use a supported version for the best MSN experience.

Novavax says its Covid vaccine is 90% effective in late stage trial

Biotech firm Novavax said its Covid-19 vaccine was shown to be safe and 90.4% effective overall in a phase three clinical trial. CNBC's Becky Quick and Meg Tirrell discuss.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon